|
|
USP-1078245 |
USP |
Budesonide Related Compound E - (16aIpha,17 -[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4, 14-triene-3,20-dione) 25 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1078267 |
USP |
Budesonide Related Compound G - (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) 25 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1078289 |
USP |
Budesonide Related Compound L (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) 25 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1078325 |
USP |
Bumetanide Related Compound A - 3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid 10 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1078336 |
USP |
Bumetanide Related Compound B - 3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1078507 |
USP |
Bupivacaine Hydrochloride ((±)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride, monohydrate) 300 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1078518 |
USP |
Bupivacaine Related Compound A - 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide 50 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1078529 |
USP |
Bupivacaine Related Compound B (N-(2,6-Dimethylphenyl)piperidine-2-carboxamide Hydrochloride) 50 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1078573 |
USP |
Buspirone Related Compound A (75 mg x 2) - (2-(Piperazin-1-yl)pyrimidine) 2 x 75 mg |
|
1,568.00 CHF
1,704.42 €
|
|
